0001356090 false 0001356090 2021-08-09 2021-08-09 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

UNITED STATES  

SECURITIES AND EXCHANGE COMMISSION  

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

 of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): August 9, 2021

 

 

Precigen, Inc.

 

(Exact name of registrant as specified in its charter)

 

         
Virginia   001-36042   26-0084895

(State or other jurisdiction

of incorporation)

 

(Commission 

File Number) 

 

(I.R.S. Employer 

Identification No.) 

 

20374 Seneca Meadows Parkway, Germantown, Maryland 20876

(Address of principal executive offices) (Zip Code)

 

(301) 556-9900 

(Registrant’s telephone number, including area code)

 

N/A  

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to 12(b) of the Act:

 

Title of each class

Trading 

Symbol(s) 

 

Name of each exchange 

on which registered 

Common Stock, No Par Value   PGEN   Nasdaq Global Select Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

Item 2.02. Results of Operations and Financial Condition.

 

Attached as Exhibit 99.1 is a copy of a press release of Precigen, Inc., dated August 9, 2021, reporting its financial results for the three months ended June 30, 2021.

 

This information, including the Exhibit attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

 

Item 9.01. Financial Statements and Exhibits.

 

(d)        Exhibits.

 

Exhibit 

No.

  Description
     
99.1   Press release dated August 9, 2021
     
104   Cover Page Interactive Data File (formatted as inline XBRL with applicable taxonomy extension information contained in Exhibits 101)

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

     
  Precigen, Inc.
     
  By:

/s/ Donald P. Lehr 

    Donald P. Lehr
    Chief Legal Officer

 

Dated: August 9, 2021

 

 

 

 

 

 

 

 

 

 

 

Precigen (NASDAQ:PGEN)
Historical Stock Chart
From Nov 2021 to Dec 2021 Click Here for more Precigen Charts.
Precigen (NASDAQ:PGEN)
Historical Stock Chart
From Dec 2020 to Dec 2021 Click Here for more Precigen Charts.